You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cutaneous Squamous Cell Carcinoma in situ

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Cutaneous Squamous Cell Carcinoma Trial in Guangzhou (IBI318)

Active, not recruiting
  • Advanced Cutaneous Squamous Cell Carcinoma
  • Guangzhou, China
    Sun Yat-sen University Cancer Center
Oct 10, 2022

Recurrent Head and Neck Squamous Cell Carcinoma, Metastatic Head-and-neck Squamous-cell Carcinoma, Locally Advanced Cutaneous

Active, not recruiting
  • Recurrent Head and Neck Squamous Cell Carcinoma
  • +3 more
  • 200 mg Pembrolizumab
  • +2 more
  • Miami, Florida
  • +6 more
Jan 9, 2023

Cutaneous Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma of the Head and Neck Trial in Tucson, Tampa

Terminated
Has Results
  • Cutaneous Squamous Cell Carcinoma
  • Cutaneous Squamous Cell Carcinoma of the Head and Neck
  • Tucson, Arizona
  • +1 more
Nov 2, 2022

Superficial Basal Cell Carcinoma, Squamous Cell Carcinoma in Situ Trial in Boston, Quincy (Combination cream of 5-fluorouracil

Recruiting
  • Superficial Basal Cell Carcinoma
  • Squamous Cell Carcinoma in Situ
  • Combination cream of 5-fluorouracil and calcipotriene
  • 5-fluorouracil cream
  • Boston, Massachusetts
    Boston Medical Center Dermatology Clinic
Nov 9, 2022

Anal Intraepithelial Neoplasia and Anal Squamous Cell Carcinoma

Recruiting
  • Anal Cancer
  • Anal Squamous Intraepithelial Neoplasia
    • London, United Kingdom
      Imperial College London- Chelsea and Westminster NHS Foundation
    Apr 19, 2023

    Cutaneous Squamous Cell Carcinoma, Skin Cancers - Squamous Cell Carcinoma Trial in Pittsburgh (Microneedle Array Doxorubicin

    Not yet recruiting
    • Cutaneous Squamous Cell Carcinoma
    • Skin Cancers - Squamous Cell Carcinoma
    • Microneedle Array Doxorubicin (MNA-D)
    • Pittsburgh, Pennsylvania
      University of Pittsburgh Medical Center
    Nov 28, 2022

    Cutaneous Melanoma, Stage III, Cutaneous Melanoma, Stage IV, Merkel Cell Carcinoma Trial (IFx-Hu2.0)

    Available
    • Cutaneous Melanoma, Stage III
    • +3 more
    • IFx-Hu2.0
    • (no location specified)
    Aug 5, 2022

    Decisional Conflicts, Health-related QoL and Satisfaction With

    Recruiting
    • Cutaneous Squamous Cell Carcinoma
    • +9 more
    • Regular care with additionally administration of questionnaires
    • Nijmegen, Gelderland, Netherlands
    • +1 more
    Jul 28, 2022

    RXR-a in Cutaneous Squamous and Basal Cell Carcinoma

    Not yet recruiting
    • Non-melanoma Skin Cancer
      • (no location specified)
      Sep 20, 2022

      Cutaneous Squamous Cell Carcinoma of the Head and Neck, Head Neck Cancer Trial in Camperdown, Herston, Woolloongabba

      Recruiting
      • Cutaneous Squamous Cell Carcinoma of the Head and Neck
      • Head and Neck Cancer
      • Camperdown, New South Wales, Australia
      • +2 more
      Jul 27, 2022

      Head and Neck Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, Head Neck Cancer Trial in United States (Lenvatinib

      Completed
      • Head and Neck Squamous Cell Carcinoma
      • +3 more
      • Basking Ridge, New Jersey
      • +6 more
      Oct 13, 2022

      Squamous Cell Carcinoma of the Skin Trial in Zhengzhou (Camrelizumab)

      Not yet recruiting
      • Squamous Cell Carcinoma of the Skin
      • Zhengzhou, Henan, China
        Department of Bone and Soft Tissue ,Henan Cancer Hospital
      Aug 3, 2022

      Cutaneous Squamous Cell Carcinoma Trial in Waratah, Melbourne, Nedlands (Imgatuzumab)

      Suspended
      • Cutaneous Squamous Cell Carcinoma
      • Waratah, New South Wales, Australia
      • +2 more
      May 17, 2022

      Use of Cemiplimab in Adult Patients in UK

      Active, not recruiting
      • Cutaneous Squamous Cell Carcinoma
      • No intervention
      • Reading, Berkshire, United Kingdom
        Sanofi-Aventis UK
      Aug 7, 2022

      Cutaneous Squamous Cell Carcinoma, Squamous Cell Carcinoma of Head and Neck Trial in United States (Drug: SL-172154)

      Terminated
      • Cutaneous Squamous Cell Carcinoma
      • Squamous Cell Carcinoma of Head and Neck
      • Drug: SL-172154
      • Los Angeles, California
      • +5 more
      May 18, 2022

      Squamous Cell Carcinoma Trial in Pittsburgh (Pembrolizumab Injection)

      Recruiting
      • Squamous Cell Carcinoma
      • Pembrolizumab Injection
      • Pittsburgh, Pennsylvania
        UPMC Hillman Cancer Center
      Jun 21, 2022

      Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Chengdu (Camrelizumab, Dalpiciclib 100mg,

      Recruiting
      • Esophageal Squamous Cell Carcinoma
      • Head and Neck Squamous Cell Carcinoma
      • Chengdu, Sichuan, China
        West China Hospital, Sichuan University
      Oct 25, 2023

      Cutaneous Squamous Cell Carcinoma Trial in Guangzhou (HLX07)

      Recruiting
      • Cutaneous Squamous Cell Carcinoma
      • Guangzhou, Guangdong, China
        Nanfang Hospital
      Jun 15, 2022

      Advanced Cutaneous Squamous Cell Carcinoma Trial in Atlanta, Chicago, New York (Ruxolitinib)

      Recruiting
      • Advanced Cutaneous Squamous Cell Carcinoma
      • Atlanta, Georgia
      • +2 more
      Jun 28, 2022

      Head and Neck Squamous Cell Carcinoma, Metastatic Head and Neck Squamous Cell Carcinoma, Stage IV Cutaneous Squamous Cell

      Not yet recruiting
      • Head and Neck Squamous Cell Carcinoma
      • +2 more
      • Panitumumab
      • +4 more
      • Nashville, Tennessee
        Vanderbilt University/Ingram Cancer Center
      Feb 16, 2023

      Metastatic Esophageal Squamous Cell Carcinoma Trial in Qingdao (TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1

      Recruiting
      • Metastatic Esophageal Squamous Cell Carcinoma
      • TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1 inhibitors（Sintilimab）
      • Qingdao, Shandong, China
      • +1 more
      Nov 13, 2023

      Esophageal Squamous Cell Carcinoma Trial in Wuhan (no intervention)

      Recruiting
      • Esophageal Squamous Cell Carcinoma
      • no intervention
      • Wuhan, Hubei, China
        Renmin hosptial of Wuhan University
      Jul 29, 2023

      Patient Perspectives in Squamous Cell Carcinoma Clinical Trials

      Not yet recruiting
      • Squamous Cell Carcinoma
        • San Francisco, California
          Power Life Sciences
        Jun 23, 2023

        Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable Trial in Guangzhou (Cetuximab, Zimberelimab, Docetaxel)

        Not yet recruiting
        • Hend and Neck Squamous Cell Carcinoma Locally Advanced Operable
        • Guangzhou, Guangdong, China
          Sun Yat-sen University
        Oct 24, 2023

        Esophageal Squamous Cell Carcinoma Trial in Shanghai (Sintilimab, Chemotherapy)

        Not yet recruiting
        • Esophageal Squamous Cell Carcinoma
        • Shanghai, Shanghai, China
          Fudan University Shanghai Cancer Center
        Nov 30, 2023